Open Water Rx review

Open Water Rx is one of the easier services to price before an intake. It lists compounded semaglutide injections at $169 per month and tirzepatide at $219, including provider review, medication if prescribed, shipping and ongoing support. Three- and six-month options show the full upfront charge rather than only a monthly equivalent. The consumer experience moves from Open Water Rx to Surfbound Health for enrollment and account management, so that second name should not be a surprise. Its public footer names several pharmacy partners, although the dispensing pharmacy can vary. The main cautions are ordinary recurring billing, limited refunds once the pharmacy processes an order, and a broad oral and longevity menu whose formulations need separate clinical scrutiny. It is a useful low-commitment comparison if the patient confirms dose coverage and understands the subscription.

Open Water Rx LLC describes itself as a technology and patient-connection platform rather than a medical practice, pharmacy or insurer. It operates Surfbound Health, the patient-facing service used for enrollment and continuing care. The website provides treatment information and pricing while the secure intake and patient portal use the Surfbound name. Independent licensed providers make prescribing decisions. The public pharmacy network lists Emerald, Striker, Foothills and EPIQ Scripts and says the actual partner depends on the medication and patient’s location. These names help a buyer ask concrete questions but do not determine the exact pharmacy, formulation or lot before a prescription is written. The site advertises nationwide availability across all 50 states, with product and provider restrictions and additional state workflows. Alongside weight care it lists NAD+, sermorelin and men’s health prescriptions. No insurance is required for the published cash-pay programs.

The patient picks a category and completes an online medical intake through Surfbound. A licensed provider reviews the history and can request further information before deciding whether prescribing is appropriate. The site says most reviews are asynchronous, with a phone or video interaction required in some states. It advertises review within one to two business days in many cases, followed by pharmacy preparation and shipment, rather than a guaranteed delivery date from the moment the form is completed. No treatment charge is taken if the provider does not approve medication. If a prescription is issued, shipping is discreet and included, and ongoing provider messaging and refill follow-up form part of the program. A patient changing services should confirm the next prescribed dose and documentation requirements before paying. The service’s claim to flat pricing also needs to be checked against the exact medication, quantity and formulation ordered, rather than assumed to cover any therapy in its catalog.

The one-month injection prices are $169 for compounded semaglutide and $219 for compounded tirzepatide. The published three-month totals are $495 and $645 respectively; six months cost $960 and $1,260. The pricing page explicitly says those longer plans are charged once in full upfront, while the one-month plan renews monthly until canceled. There is no separate membership or provider fee in the stated package, and approved prescriptions include shipping and ongoing support. Oral semaglutide is listed at $259 for a month, oral tirzepatide at $298 and a compounded oral combination at $365; those are different formulations rather than cheaper versions of the injection plan. NAD+ nasal spray starts at $112 for the listed 900 mg supply, while injectable and oral sermorelin have dose-dependent plans. Cancellation is available through the patient portal without an advance-notice requirement, but it stops future cycles rather than reversing an order the pharmacy has already processed. The policy describes refunds of unused subscription charges when a provider documents medical disqualification; its detailed language limits refunds to the most recent billing cycle. Damaged or incorrect medication is generally replaced rather than refunded. Confirm the selected prepaid plan’s treatment of unused supply before choosing a longer commitment.

The main injection programs contain compounded semaglutide or compounded tirzepatide. Open Water Rx clearly distinguishes these from finished branded Wegovy or Zepbound products and says compounded preparations are not FDA-approved. The presence of a named pharmacy network does not establish equivalence to the approved brands or mean a particular patient needs a compounded preparation. The oral catalog also includes semaglutide, tirzepatide and a combination; these formats require their own evidence discussion and should not inherit the results of injection trials. The longevity menu includes NAD+ nasal preparations and sermorelin by oral or injection routes, while the men’s health section lists conventional sildenafil and tadalafil as well as a sublingual combination. Ask for the exact ingredients and strength of a combination product. A large menu can simplify logistics, but convenience and a plausible mechanism are not a demonstration of benefit. The prescribing clinician should review other medications and explain why each proposed treatment is appropriate.